CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia

Ancillary testing with immunohistochemistry has shown recent promise in the workup of equivocal bladder lesions. We read with interest the recent findings of Alston et al., who assessed the diagnostic utility of alpha-methylacyl-CoA racemase (AMACR) in comparison to cytokeratin 20 (CK20) in evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Daniel J., Amin, Mahul B., Smith, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251721/
https://www.ncbi.nlm.nih.gov/pubmed/32456709
http://dx.doi.org/10.1186/s13000-020-00984-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251721/
https://www.ncbi.nlm.nih.gov/pubmed/32456709
http://dx.doi.org/10.1186/s13000-020-00984-2

Ejemplares similares